Latest filing published 01 Mar 2019 for Opus Genetics, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -71.9%Entry US$30.72 · Close at T+365 US$8.64
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Lisa Nolan: trading record in brief
All filings by Lisa Nolan on record concern Opus Genetics, Inc. The record holds 3 filings, for trades running from 28 February 2018 to 28 February 2019.
No open-market sale appears; the market trades are 1 purchase worth €11k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 2 option exercises. In 2019 alone, the filings show 1 purchase and no sales.
The newest entry dates from 1 March 2019: an option exercise, in Opus Genetics, Inc. The clock since the last published purchase (31 January 2019) now reads 2,839 days. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Lisa Nolan
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,625 shares0Common StockSEC:0001140361-19-004276:0
- 20,000 shares@ US$0.648100.0% of flowCommon StockSEC:0001140361-19-002080:0Canonical exit: 30 Apr 2019 (T+90)
- 1,625 shares0Common StockSEC:0001140361-18-011675:0
3 of 3 declarations
